Study identifier:D5130L00009
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Effectiveness of risk minimisation interventions for ticagrelor in Canada
Acute Coronary Syndrome
N/A
No
-
All
244
Observational
18 Years - 85 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2015 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Prescribers | - |